Compound ID | 851

Update compound information

Bederocin

Synonym(s): REP8839

Class: Aminoacyl-tRNA synthetase inhibitor (methionyl tRNA synthetase [MetRS] inhibitor)

Spectrum of activity: Gram-positive  &  Gram-negative
Details of activity: Protein synthesis inhibitor by inhibiting methionyl tRNA synthetase; active against MRSA and Streptococcus pyrogenes. Moderately active against Gram negatives.
Institute where first reported: GSK, USA; Replidyne, Inc., (Cardiovascular Systems, Inc, USA)
Year first mentioned: 2004
Highest developmental phase: Phase 1
Development status: Discontinued
Reason Dropped: Replidyne suspended development of this compound due to need of additional investment (S1)
Chemical structure(s):
Click here for structure editor
Molecular weight: 450.37
Iso. SMILES: CC1=C(SC(=C1Br)C(=C)F)CNCCCNC2=CC(=O)C3=CC=CC=C3N2
InChI Key: BGJMKHPWCFXMOW-UHFFFAOYSA-N
Can. SMILES: CC1=C(CNCCCNC2=CC(=O)C3=C(C=CC=C3)N2)SC(=C1Br)C(=C)F
InChI: InChI=1S/C20H21BrFN3OS/c1-12-17(27-20(13(2)22)19(12)21)11-23-8-5-9-24-18-10-16(26)14-6-3-4-7-15(14)25-18/h3-4,6-7,10,23H,2,5,8-9,11H2,1H3,(H2,24,25,26)
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/9868368
Guide to Pharmacology: bederocin
Citations:
  • http://adis.springer.com/drugs/800025207
  • https://pubmed.ncbi.nlm.nih.gov/19015366/

    • AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.